Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
India
· Delayed Price · Currency is INR 178.23
+9.96 (5.92%)
Mar 10, 2026, 12:00 PM IST
Jagsonpal Pharmaceuticals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 11,256 | 14,422 | 7,313 | 7,592 | 8,214 | 2,085 | Upgrade
|
| Market Cap Growth | -26.18% | 97.22% | -3.68% | -7.58% | 293.91% | 353.56% | Upgrade
|
| Enterprise Value | 9,752 | 13,741 | 6,290 | 7,175 | 7,748 | 1,574 | Upgrade
|
| Last Close Price | 168.27 | 215.01 | 108.21 | 112.14 | 121.33 | 29.88 | Upgrade
|
| PE Ratio | 27.74 | 26.05 | 32.55 | 28.41 | 43.57 | 12.23 | Upgrade
|
| PS Ratio | 4.00 | 5.37 | 3.50 | 3.21 | 3.78 | 1.11 | Upgrade
|
| PB Ratio | 4.45 | 6.01 | 3.90 | 4.78 | 6.19 | 1.71 | Upgrade
|
| P/TBV Ratio | 6.58 | 9.35 | 3.90 | 4.78 | 6.19 | 1.71 | Upgrade
|
| P/FCF Ratio | - | 26.24 | 20.94 | 16.39 | 140.06 | 7.51 | Upgrade
|
| P/OCF Ratio | - | 26.08 | 20.80 | 16.27 | 118.81 | 7.39 | Upgrade
|
| EV/Sales Ratio | 3.46 | 5.11 | 3.01 | 3.03 | 3.56 | 0.84 | Upgrade
|
| EV/EBITDA Ratio | 16.54 | 27.69 | 28.44 | 20.67 | 30.37 | 7.92 | Upgrade
|
| EV/EBIT Ratio | 21.11 | 32.00 | 29.11 | 21.18 | 32.30 | 8.38 | Upgrade
|
| EV/FCF Ratio | - | 25.01 | 18.01 | 15.49 | 132.10 | 5.67 | Upgrade
|
| Debt / Equity Ratio | 0.04 | 0.04 | 0.05 | 0.04 | - | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 0.15 | 0.18 | 0.38 | 0.17 | - | 0.34 | Upgrade
|
| Debt / FCF Ratio | - | 0.17 | 0.26 | 0.13 | - | 0.25 | Upgrade
|
| Net Debt / Equity Ratio | -0.59 | -0.50 | -0.74 | -0.68 | -0.35 | -0.45 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.61 | -2.41 | -6.29 | -3.13 | -1.84 | -2.79 | Upgrade
|
| Net Debt / FCF Ratio | - | -2.17 | -3.98 | -2.34 | -8.02 | -2.00 | Upgrade
|
| Asset Turnover | - | 1.09 | 1.01 | 1.32 | 1.33 | 1.20 | Upgrade
|
| Inventory Turnover | - | 6.42 | 4.52 | 3.68 | 3.02 | 2.75 | Upgrade
|
| Quick Ratio | - | 5.48 | 8.31 | 4.92 | 2.32 | 1.89 | Upgrade
|
| Current Ratio | - | 6.22 | 10.29 | 5.97 | 4.04 | 2.98 | Upgrade
|
| Return on Equity (ROE) | - | 25.91% | 12.97% | 18.32% | 14.81% | 14.64% | Upgrade
|
| Return on Assets (ROA) | - | 10.84% | 6.55% | 11.79% | 9.13% | 7.51% | Upgrade
|
| Return on Invested Capital (ROIC) | 33.87% | 40.30% | 32.94% | 36.65% | 22.30% | 20.33% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 17.00% | 10.90% | 20.20% | 17.50% | 15.20% | Upgrade
|
| Earnings Yield | 3.63% | 3.84% | 3.07% | 3.52% | 2.30% | 8.18% | Upgrade
|
| FCF Yield | - | 3.81% | 4.78% | 6.10% | 0.71% | 13.31% | Upgrade
|
| Dividend Yield | 1.44% | 1.16% | 1.85% | 1.78% | 1.32% | 1.34% | Upgrade
|
| Payout Ratio | - | 23.90% | 58.31% | - | 55.58% | 15.36% | Upgrade
|
| Buyback Yield / Dilution | -0.36% | -1.56% | -1.23% | - | - | - | Upgrade
|
| Total Shareholder Return | 1.08% | -0.39% | 0.62% | 1.78% | 1.32% | 1.34% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.